Planning Center Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$781K Sell
3,075
-4
-0.1% -$932 0.07% 39
2026
Q1
$753K Buy
3,079
+509
+20% +$119K 0.08% 39
2025
Q4
$532K Hold
2,570
0.05% 46
2025
Q3
$477K Sell
2,570
-4
-0.2% -$685 0.05% 45
2025
Q2
$393K Hold
2,574
0.04% 48
2025
Q1
$427K Buy
2,574
+273
+12% +$42.7K 0.05% 48
2024
Q4
$333K Sell
2,301
-119
-5% -$18.4K 0.04% 51
2024
Q3
$392K Buy
2,420
+2
+0.1% +$319 0.05% 49
2024
Q2
$353K Sell
2,418
-30
-1% -$4.46K 0.05% 49
2024
Q1
$387K Buy
2,448
+81
+3% +$12.9K 0.08% 42
2023
Q4
$371K Sell
2,367
-7
-0.3% -$1.07K 0.09% 41
2023
Q3
$370K Sell
2,374
-111
-4% -$18.3K 0.1% 41
2023
Q2
$411K Buy
2,485
+175
+8% +$28.2K 0.1% 37
2023
Q1
$384K Sell
2,310
-208
-8% -$33.6K 0.11% 38
2022
Q4
$445K Sell
2,518
-21
-0.8% -$3.63K 0.14% 37
2022
Q3
$413K Sell
2,539
-31
-1% -$5.25K 0.33% 22
2022
Q2
$458K Buy
2,570
+34
+1% +$6.06K 0.36% 23
2022
Q1
$449K Hold
2,536
1.29% 17
2021
Q4
$438K Buy
+2,536
New +$415K 0.35% 24

Other funds holding JNJ

Planning Center Inc's JNJ Position: Q2 2026 in Review

Planning Center Inc reduced its Johnson & Johnson (JNJ) stake by 0.13% in Q2 2026, selling an estimated $932 and leaving 3,075 shares worth $781K. The position accounts for 0.07% of the portfolio, ranked #39.

Planning Center Inc first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Planning Center Inc held 3,075 shares of Johnson & Johnson worth $781K as of Q2 2026.
  • Planning Center Inc sold 4 Johnson & Johnson shares in Q2 2026, an estimated $932.
  • Johnson & Johnson made up 0.07% of Planning Center Inc's portfolio in Q2 2026, its #39 holding.
  • Planning Center Inc first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Planning Center Inc's 13F filing for Q2 2026, filed 30 Jul 2026.